IPO - Nanobiotix S.A.

Form Type: F-3

Filing Date: 2025-03-06

Corporate Action: Ipo

Type: New

Accession Number: 000114036125007433

Filing Summary: Nanobiotix S.A. filed a registration statement under the Securities Act of 1933 on March 6, 2025, to register securities totaling up to $200,000,000, which includes ordinary shares, preferred shares, and warrants. The filing allows Nanobiotix to conduct public offerings and capital raises in the future, with the ability to offer securities from time to time. The company is also registering 5,623,816 ordinary shares for a selling shareholder to fulfill contractual registration rights. The ordinary shares can be offered in the form of American Depositary Shares (ADS) with each ADS representing one ordinary share. The last reported sale price of their ADS on the Nasdaq Global Select Market was $3.48, and their ordinary shares on Euronext Paris was €3.274. The registration is part of a 'shelf' process allowing continuous or delayed offerings without needing to file a new application each time. The company emphasized risks associated with the investment in their securities, particularly those connected to their lead product candidate, NBTXR3, which is a potential first-in-class radioenhancer for cancer therapy.

Document Link: View Document